Navigation Links
MedImmune To Present Eight Abstracts on Projects Regarding Thoracic and Respiratory Issues at the Annual American Thoracic Society International Conference
Date:5/13/2011

GAITHERSBURG, Md., May 13, 2011 /PRNewswire/ -- MedImmune announced today it will present eight abstracts at the American Thoracic Society (ATS) International Conference in Denver, CO, May 13-18, 2011.  "These data advance our understanding of thoracic diseases, highlighting our continued commitment to help improve patient health," said Bing Yao, Senior Vice President and Leader of the RIA innovative Medicines Unit (iMED) at MedImmune.

MedImmune abstracts to be presented at the ATS International Conference include:

  • IL-1 Family Members Have Different Effects on the Innate Pro-inflammatory and Anti-viral Responses of Epithelial Cells to Rhinovirus. Briend E, et al. Poster Session: May 16, 2011 Time: 10:45 - 12:30 PM,  Colorado Convention Center Area J, Hall B (Upper Level)
  • Cytokine Profiling in Severe Asthma Sub-phenotypes Using Factor and Cluster Analysis. Desai D, et al. Poster Session: May 16, 2011 Time: 3 - 3:15 PM, HRD Ballroom A-B-C (3rd Level)
  • Expression Patterns of Interleukin-1 Receptor 1 in COPD Patients, Smokers and Never-smoking Control Subjects. Bergqyist A, et al. Poster Session: May 16, 2011 Time: 8:15 AM – 4:30 PM, Colorado Convention Center Area E, Hall B (Upper Level)
  • Full Length IL-33 Activates Primary Human Mast Cells and It's Inhibited by Neutralising Antibodies. Cohen S, et al. Poster Session: May 17, 2011 Time: 8:15 AM – 4:30 PM, Colorado Convention Center Area F, Hall B (Upper Level)
  • The Epithelial-derived Signals TSLP, IL-25 and IL-33 Converge on OX40L to Elicit House-dust Mite 0 Induced Allergic Airway Inflammation in Mice. Llop-Guerva A, et al. Poster Session: May 16, 2011 Time: 8:15 AM – 4:30 PM, Colorado Convention Center Area K, Hall B (Upper Level)
  • In Vitro Cellular Response to Respiratory Syncytial Virus and Human Rhinovirus Infection of Primary Human Airway Epithelial Cells Derived From Healthy and COPD/Asthmatic Donors. Svabek C, et al. Poster Session: May 15, 2011 Time: 8:15 AM – 4:30 PM, Colorado Convention Center Area J, Hall B (Upper Level)
  • Comparison of the Preventative, Therapeutic and Prophylactic Effects of Anti-g and Anti-f RSV Glycoprotein Antibodies in the Response to Primary and Secondary RSV Infection. Han J, et al. Poster Session: May 18, 2011 Time: 2 – 4:30 PM, Colorado Convention Center Rooms 503-504 (Street Level)
  • Longitudinal Measures of Pulmonary Function in Healthy Late Preterm Infants Delivered at 33-36 Weeks of Gestation. McEvoy C, et al. Poster Session: May 16, 2011 Time: 2 – 4:30 PM, Colorado Convention Center Rooms 501-502 (Street Level)

Additional information about the 2011 ATS conference can be found at: http://conference.thoracic.org/

About MedImmune

MedImmune, the global biologics business for AstraZeneca PLC (LSE: AZN.L, NYSE: AZN), has approximately 3,500 employees worldwide and is headquartered in Gaithersburg, Maryland. With an advancing pipeline of promising drug candidates, MedImmune strives to deliver life-changing products, rewarding careers to our employees and a tireless commitment to improving patient health. For more information, visit MedImmune's website at www.medimmune.com


'/>"/>
SOURCE MedImmune
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pfenex Announces Strategic Collaboration With MedImmune for the Use of Pfenex Expression Technologyâ„¢
2. MedImmune to Present 11 Abstracts on Influenza at 45th Annual National Immunization Conference
3. MedImmune In-Licenses Clinical-Stage Anti-Inflammatory Monoclonal Antibody From Amgen
4. MedImmune Announces Winners of the 5th Annual Respiratory, Inflammation and Autoimmunity Research Abstract Competition
5. MedImmune Focused on Revolutionizing Cancer Care
6. MedImmune to Present Five Abstracts on RSV at Pediatric Academic Societies Annual Meeting
7. MedImmune to Present Data on RSV and Influenza at 2009 American Academy of Pediatrics National Conference & Exhibition
8. MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants
9. MedImmune Presents New Data Demonstrating Increased Risk for Medically Attended RSV in Late-Preterm Infants
10. MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine
11. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... 2016 Story Highlights: ... within the health care industry is causing providers to ... , Deloitte offers a suite of solutions for health ... efficient cost optimization: labor resource analysis, revenue cycle optimization ... better outcomes and better economics ...
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, Inc., ... development and manufacturing of collagen and mineral based ... today that Bill Messer has joined ... to further leverage the growing portfolio of oral ... Bill joins the Collagen Matrix executive ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative ... has initiated cultivation and processing operations at its production facility, and opened its ... Puradigm is the manufacturer of a complete system of proactive air and surface ...
Breaking Medicine News(10 mins):